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the study period. Controls were selected based on a propensity score methodology 
ensuring exactly the same baseline lung disease distribution between the 2 groups 
and no medical claim for PH across the entire study period. RESULTS: A total of 2,236 
cases met study criteria. On average, cases were significantly (p< 0.01) younger (67 vs. 
71), more females (64% vs 58%) and higher comorbid burden (2.8 vs 2.09) compared 
to controls. After adjusting for all baseline characteristics cases had significantly 
higher (p< 0.001) inpatient admissions (5.0 vs 2.4), physician office visits (16.5 vs 
12.5), emergency room visits (0.7 vs 0.5), pharmacy claims (67 vs 54). This translated 
into higher expenditures among cases ($42,914) vs controls ($16,745) at per patient 
per year level. CONCLUSIONS: Using health plan data this study showed that Group 
3-PH poses a significant economic burden to payers.
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OBJECTIVES: To estimate the direct medical costs of severe acute respiratory infec-
tion (SARI) in children and adults from three Central American countries whit a 
bottom-up costing approach. METHODS: The costs of inpatients treatment were 
estimated through the retrospective bottom-up costing in a randomized sample of 
clinical records from SARI patients treated in teaching tertiary hospitals during 2009 
- 2011 period. Activities incurred per patient were registered and a setting-specific 
cost per activity was acquired. Average cost per patient in the group of children and 
elderly adults was estimated for each country. In Nicaragua, only the pediatric popu-
lation was included. Costs were expressed in local currency (2011), American dollars, 
and international dollars (2005) for country comparison. RESULTS: The care cost per 
case in children in Guatemala was the cheaper (I$971.95) compared to Nicaragua 
(I$1,431.96) and Honduras (I$1,761.29). In adults, the treatment cost for Guatemala 
was the more expensive: I$4,065.00 vs. I$2,707.91 in Honduras. CONCLUSIONS: 
Bottom-up costing of SARI cases allowed the mean estimates per treated case that 
could have external validity for the target population diagnosed in hospitals with 
similar epidemiological profiles and level of complexity for the study countries. This 
information is very relevant for the decision-making.
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OBJECTIVES: To investigate racial disparities in the incidence of skeletal-related 
events (SREs) and healthcare utilization costs associated with SREs among older 
African American (AA) and non-Hispanic White (NHW) men with advanced prostate 
cancer (PCa). METHODS: We identified men aged 66 or older, diagnosed with stage 
IV metastatic PCa between 2000 and 2007 from the SEER-Medicare dataset. Three 
mutually exclusive SRE categories were created for pathologic fracture (PF), spinal 
cord compression (SCC), and bone surgery (BS). Multivariable logistic regression 
models were used to assess the relationship between SREs and race, controlling 
for other demographic, clinical, and treatment characteristics. The annual unad-
justed post-SRE healthcare utilization costs included total monthly costs in the 
12-month post-period relative to the first SRE. Difference-in-difference estimates 
were derived in a propensity score matched sample to obtain annual adjusted SRE-
specific costs. We estimated unadjusted post-SRE and adjusted SRE-specific cost 
differences between AA and NHW men. RESULTS: Application of inclusion criteria 
resulted in 6,455 metastatic PCa patients with 1,035 AA and 5,420 NHW men. A 
higher proportion of NHWs (16%) experienced SREs compared to AAs (13%) (p< 0.01). 
The likelihood of experiencing SREs among AAs was lower than in NHWs after 
adjusting for individual characteristics (OR:0.81,95%CI:0.68-0.96,p= 0.02), specifi-
cally due to the lower likelihood PF and BS events among AA men. The unadjusted 
post-SRE costs among AAs were US$12,962 (95%CI:US$3,995-US$21,930;p< 0.01) 
higher compared to NHW men. However, the adjusted SRE-specific cost differ-
ences between AA and NHW men were not statistically significant. The adjusted 
SRE-specific costs were US$35,725 (95%CI:US$22,190-US$49,260) among AAs, and 
US$25,896 (95%CI:US$21,669-US$30,123) among NHWs. SRE-specific costs varied 
by SRE type, with BS costing more than PF and SCC events. CONCLUSIONS: Even 
though AA men were less likely to experience SREs than NHWs, the observed trend 
towards higher costs in advanced PCa care among AA men highlight the need for 
further research with larger, racially diverse samples.
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OBJECTIVES: Colorectal cancer (CRC) is the third most common cancer in both 
male and female in the world. Therefore, CRC causes the high economic burden 
for both patients and society. Understanding the cost of CRC is necessary to con-
duct the relevant healthcare policies, especially in Vietnam. This is also the aim of 
this study. METHODS: A decision tree model was built to analyze the cost of each 
stage based on the National Comprehensive Cancer Network Guideline in 2013. The 
average cost of CRC was evaluated by using the following formula: COI = DC + IC. 
In which: COI - cost of illness, DC- direct cost, IC- indirect cost . The analysis was 
dration-$12,100 chemotherapy administration). For children 10-14 years, affective 
psychoses had the longest LOS (mean LOS= 7.5 days; range: 1.6 acute appendicitis-4.5 
chemotherapy administration), and chemotherapy administration had the greatest 
cost (mean cost= $13,295; range: $3,790 asthma with acute exacerbation-$11,999 acute 
appendicitis). CONCLUSIONS: Children in the US are hospitalized for a variety of 
reasons, with respiratory illnesses (i.e., pneumonia, asthma, and bronchiolitis) being 
common in all age groups. The LOS associated with the most common reasons for 
hospitalization is typically short with mean costs not exceeding $14,000.
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OBJECTIVES: Estimate direct medical costs of selected acute complications in 
patients with non-valvular atrial fibrillation (NVAF) at a private hospital “Clínica 
Santa Sofía” in Venezuela. METHODS: The hospital´s Medical Statistics Department 
was used to identify the study population. CIE-10 codes were used to identify 
patients with NVAF and select complications of AF. Complications of interest are: 
ischemic stroke, hemorrhagic stroke, systemic embolism, myocardial infarction, 
gastrointestinal hemorrhage and non-neurological hemorrhage. All cases from 2012 
-2013 meeting the inclusion criteria were reviewed. Patient level data from clinical 
charts was extracted to estimate resource utilization per patient per event. Costs 
were estimated using the hospital’s 2014 tariffs and expressed per patient in 2014 
Bolívares Fuertes (BsF). RESULTS: Mild and moderate ischemic stroke costs were 
estimated at BsF. 79,114 (SD 103,903), BsF 90,266 (SD 97,934). One case of mild, and 
one case of moderate ischemic stroke consumed high healthcare resources in this 
study population. Only one case of severe fatal ischemic stroke was identified and 
costs were estimated at BsF 14,143. No hemorragic stroke events were collected. 
Systemic embolism and myocardial infarction costs accounted for BsF 79,846 and 
BsF 36,332 (SD 13,865) respectively. Gastrointestinal hemorrhage was estimated at 
BsF 16,229 (SD 1,841) and only 1 event of non-neurological hemorrhage was col-
lected and costs estimated at BsF 8,864. CONCLUSIONS: Direct medical costs for 
NVAF patients at this private hospital increase as the severity of the event. High 
variability in costs was observed. Estimating these costs could help clinicians and 
decision makers a better understanding on the importance of preventing these 
complications with adequate NVAF treatment.
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Multiple sclerosis (MS) is an inflammatory demyelinating disease of central nerv-
ous system. It affects more than 1 million people in the world and the estimated 
prevalence in Colombia is of 4 to 5 per 100,000 inhabitants. It is a high cost disease 
and the drugs for its treatment were included to the benefit plan of health system 
since 2014.OBJECTIVES: Estimate the direct costs associated with the health care of 
patients with MS insured with a health manteinance organization (HMO) in Colombia 
during the period 2010-2014. METHODS: A retrospective cross-sectional study was 
conducted in a cohort of 163 patients distributed in 13 cities of the country and affili-
ated with a HMO in Colombia during January 2010 to December 2014. Demographic 
characteristics of the cohort are described and the average annual costs were esti-
mated by health service and patient. Costs were adjusted for inflation and expressed 
in 2014 US dollars. RESULTS: The prevalence of MS was 7.85 per 100,000 persons, the 
69.94% were female, the mean age was 40.91 years (SD 12.57 years), and cities with 
higher concentrations of patients were Bogotá (47%), Barranquilla (16%) and Medellin 
(9%). The average annual cost of care for the 163 patients was $ 2,663,500.79, mainly 
because drugs (85.39%), followed by diagnostic and therapeutic procedures (8.58%), 
magnetic resonance (1.21%), hospitalization (1.19%) and specialized consultations 
(0.92%). The average annual cost per patient was $ 21,303.43 (2010), $ 17,842.61 (2011), $ 
22,327.09 (2012), $ 22,662.90 (2013) and $ 20,205.28 (2014). CONCLUSIONS: The average 
annual cost per patient of MS in an insured population in Colombia corresponds to 
the annual premium per capita of 68 patients by 2014. Despite the change of technol-
ogy in the pharmacological treatment of these patients, there was not a significant 
increase in health care costs during the follow.
PHS35
incremental burden of grouP 3 Pulmonary HyPertenSion PatientS 
to u.S. Payer
Heresi G.A.1, Joish V.N.2, Platt D.3, Abad M.4, Kamalakar R.3, Teal S.4, Satler C.3
1Department of Pulmonary and Critical Care Medicine, Cleveland, OH, USA, 2Bayer Healthcare 
Pharmaceuticals, Whippany, NJ, USA, 3BAYER HEALTHCARE PHARMACEUTICALS, WHIPPANY, 
NJ, USA, 4Bayer Pharma AG, Berlin, Germany
OBJECTIVES: Pulmonary hypertension (PH) is classified into 5 groups. Group 3-PH 
is PH associated with lung diseases, such as chronic obstructive pulmonary dis-
ease (COPD), interstitial lung diseases (ILD), or those associated with sleep-related 
breathing disorders. We estimated the burden of Group 3 PH patients to US pay-
ers. METHODS: A 1:1 case-control study design using a large health insurance 
claims database was employed. Group 3-PH patients were identified using the fol-
lowing inclusion criteria: ≥ 2 medical claims for PH during July 1 2011 through June 
30 2012; at least one procedural claim for echocardiogram or right heart catheteriza-
tion, and at least one medical claim for COPD, ILD, breathing sleep disorders, alveolar 
hypoventilation disorder, chronic exposure to high altitude, or developmental lung 
diseases. Patients were excluded if they had a medical claim for left heart disease, 
pulmonary embolism, hematologic disorders, systemic disorders, metabolic disor-
ders or other categories as described in the 2013 classification of PH anytime during 
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age annual costs were estimated by health service and patient. Costs were adjusted 
for inflation and expressed in 2014 US dollars. RESULTS: The prevalence of BC was 
247.72 per 100,000 members, the average age was 58.86 years (SD 13.05 years), cit-
ies with higher concentrations of patients were Bogotá (35.08%), Medellin (10.65%), 
and Barranquilla (9.67%). The average annual cost of health care for 1314 patients 
was $ 5,709,078.15, given mainly by chemotherapy with 31.36%, followed by drugs 
(27.34%), radiotherapy (7.48%), hospital surgery (6.26%), diagnostic and therapeu-
tic procedures (3.55 %) and hospitalization (3.22%). The average annual cost per 
patient was $ 8350.95 (2010), $ 7798.91 (2011), $ 6719.66 (2012), $ 5910.49 (2013) and 
$ 5214.47 (2014). CONCLUSIONS: The average annual cost per patient with BC in 
an insured population in Colombia is equivalent to the annual premium per capita 
of 17 patients by 2014. I an average decrease in cost per patient of 38% was found 
during the follow.
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OBJECTIVES: Simple contact dermatitis (CD) and pressure ulcers (PU) of immobi-
lized patients with urinary is an important and not enough explored clinical and 
economic problem in hospitals and social care organizations. METHODS: An obser-
vational clinical and economic study of a typical practice of CD and PU. In the study 
taken forms of 85 patients, analyzed in 7 critical points each. Patients had a higher 
risk of CD and PU. The average age - 76 ± 5,6 years. RESULTS: Patients without CD 
and PU - 25 persons (29.8%), with PU 50 persons (58.8%), with CD 35 persons (41.1%). 
In 19 patients (22.4%) had and PU and CD in various critical areas. CD was marked in 
75 points (12.6%), PU 1-2st - 93 points (15.6%), PU 3-4st - 8 points (1.3%). Total costs 
in rubles (1$ US = 34 ₷) for 1 patient in the group without the CD and PU were 12895, 
drugs -325, on care products -391, for services -12179. In the group “PU 1-2st” total 
costs 13546, on drugs -267, at the expense of care -769, for services -12510. In the 
group “PU 3-4st “ total costs 25290, on drugs –161, on care products -4356, for services 
- 20 773. In the group of “KD” total costs 16027, on drugs -146, on care products 1349, 
for services – 14532. CONCLUSIONS: The frequency of PU is 58.8%, KD - 41.1%, KD 
and PU - 22.4%. Without CD and PU - 29.8%. Total costs are the biggest in group of 
patients with high degrees of PU, due to the high cost of services and care products. 
Drug costs are not high. A high cost in the CD group is associated with services and 
care. The data will be used to construct a Markov model.
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OBJECTIVES: Colorectal cancer (CRC) is considered as the third common cancer 
among men and the second common cancer among women worldwide. In Vietnam, 
colorectal cancer is the fifth common cause of cancer - related incidence. In many 
countries, economic burden of colorectal cancer has been investigated logically. 
However, there have not had any research about this in Vietnam. This research was 
conducted to provide more detail information to help the decision-makers find out 
the most appropriated policies to control the disease. METHODS: The economic bur-
den of CRC in Vietnam was evaluated by the following formula: C = ∑Pi x COIi.; in 
which, C: economic burden of CRC in Vietnam, Pi: number of patients in stage i of CRC 
in Vietnam, COIi: cost of CRC in stage i. RESULTS: The 5-year prevalence of CRC is 27.3 
per 100,000. The economic burden of CRC of the whole society was estimated about 
14,268.3 billion VND. The values fluctuated sharply from stage I to stage IV, accounted 
for 6.9 billion VND; 5,731.2 billion VND; 3,564.5 billion VND and 4,965.7 billion VND, 
respectively. As lots of patients were diagnosed at stage II (about 38%), the economic 
burden of this stage was predominant (40%) compared to the others. Furthermore, 
in all stages except stage I, the economic burden related to medicine was much more 
higher than that of medical services. CONCLUSIONS: The high economic burden 
of CRC should be considered to conduct relevant healthcare policies, especially for 
patients in advanced stages. key word: economic burden, colorectal cancer.
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OBJECTIVES: In 2013 December, PAHO confirmed the local circulation of chikungu-
nya virus (CHKV) in the region. In 2014 September Colombia reported the first local 
CHKV case in the Bolívar, and started an outbreak within a susceptible population. 
The objective of this analysis is to estimate the medical care cost of children patients 
with suspect of CHKV attended at a reference pediatric Hospital in Cartagena-
Bolivar, at the start of the CHKV local transmission in Colombia. METHODS: A ret-
rospective bottom-up cost analysis was designed. We selected randomized sample 
of clinical records from children patients with CHKV clinically suspected during 
September – November 2014 at the Hospital “Napoleón Franco Pareja” in Cartagena 
city, Colombia. A costing data collection instrument was designed a piloted to col-
lect the information about the frequency of use activities and supplies by patient. 
Administrative and cost data by patient and activity were obtained from the 
Hospital. Costing items included: consults, hospitalization bed-day, supplies, drugs, 
and diagnosis and therapeutic procedures. Total cost per cost item and patient were 
estimated and average cost per patient reported. Costs were expressed in 2014 USD 
with an Exchange rate of 2392.46 COP per American dollar. RESULTS: A sample of 
conducted based on the perspective of healthcare payers; therefore, only medical 
direct cost was evaluated. The cost of medical service and drugs were retrieved 
from the price-list of relevant medical services and drugs, registered by Ministry of 
Health in Vietnam 2012. RESULTS: The average direct cost of CRC for one patient 
accounted for nearly 756.83 million VND per year. Cost for one patient increased 
with the increasing of disease severity and accounted for 1.875 million VND; 800 mil-
lion VND; 822 million VND and 1,351 million VND in stage I, II, III, IV, respectively. In 
the structure of cost, with the increase in severity of disease, the percentage of drug 
cost increased and the percentage of medical services decreased. CONCLUSIONS: 
The cost of CRC treatment increased following the increase of disease severity. The 
huge economic impact of CRC should be controlled and considered to conduct the 
proper healthcare policies.
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OBJECTIVES: To examine the association of direct medical costs with clinical and 
health characteristics in visually impaired individuals in Singapore. METHODS: 
We prospectively recruited 500 visually impaired individuals due to cataract, glau-
coma, diabetic retinopathy (DR), or age-related macular degeneration (AMD) from 
Singapore National Eye Centre. In face-to-face interviews, vision function and health 
status of the individuals were assessed using the 14-item Visual Functioning (VF-14) 
and EQ-5D questionnaires, respectively. Severity of visual impairment (VI) and direct 
medical costs were determined using clinical and billing data, respectively, in the 
study center. Annual medical costs per capita were estimated and compared for 
individuals with different eye diseases and in different levels of VI, vision function, 
and health status using generalized linear models. RESULTS: The mean (standard 
deviation [SD)] age of participants was 71.6 (9.8) years old. The proportion of male 
was 47.6% and the mean (SD) presenting visual acuity was 0.49 (0.31). The annual 
medical costs per capita were S$6.8K. After adjusting for socio-demographics, the 
annual medical costs differed in individuals with different eye diseases (AMD 
higher than cataract by S$13.1K, glaucoma by S$9.2K, and DR by S$12.4K), VI sever-
ity (between mild/moderate and severe VI: S$8.8K), vision function (between absence 
and presence of problems: S$3.7K), and health status (between absence and pres-
ence of problems: S$1.3K). CONCLUSIONS: Direct medical costs are highest in AMD 
individuals and are associated with clinical measure and vision function in visually 
impaired individuals in Singapore.
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OBJECTIVES: Vaccination against influenza, pneumococcal disease and herpes zos-
ter are recommended for the elderly, who have high morbidity and mortality rates 
due to these three diseases. Many studies investigated the clinical burden by each 
vaccine-preventable disease; however, empirical data on the full economic burden 
of adult vaccine-preventable diseases is scarce. This study examines the healthcare 
resource utilization and medical expenditures of elderly with vaccine-preventable 
diseases in Taiwan. METHODS: We included 104,273 beneficiaries aged 65 years or 
older under the Taiwan’s National Health Insurance program in 2010. Patients with 
vaccine-preventable diseases were defined as those who had at least one diagno-
sis of flu, pneumococcal disease, or herpes zoster. Outcomes of interest include 
healthcare resource utilization (inpatient, outpatient, and emergency department 
(ED) visits) and associated medical expenditures. RESULTS: In 2010, there were 
6.77%, 3.18% and 1.88% of elderly population had been diagnosed and received 
ambulatory care for pneumonia, flu and herpes zoster, respectively. However, on 
average, patients with pneumonia, flu, herpes zoster visited the doctor’s office 36.9, 
37.3, 38.5 times (without those diseases: 26.7 times), respectively. The healthcare 
resource utilization from patients with vaccine-preventable diseases attributed to 
large proportion of medical expenditures. Among annual medical expenditures 
for the elderly (US$0.2 billion), 13.08% of expenditures cost from pneumonia care, 
3.10% from flu and 2.53% from herpes zoster. Average cost per patient were US$3.6 
thousand, US$1.8 thousand and US$ 2.5 thousand for pneumonia, flu and herpes 
zoster, respectively. CONCLUSIONS: This study demonstrates significant burden of 
healthcare utilization caused by older people with vaccine-preventable diseases. In 
addition, different management strategies may be warranted for different vaccine-
preventable diseases since the differences of patient characteristics as suggested 
by our study.
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Breast cancer (BC) is one of leading causes of death in women and is also considered 
a catastrophic illness associated with a large financial burden on the health system 
with incremental trend.OBJECTIVES: To estimate the direct costs associated with 
the health care of patients with BC affiliated with a health manteinance organiza-
tion (HMO) in Colombia during the period 2010-2014. METHODS: A retrospective 
cross-sectional study was conducted in a cohort of 1314 patients with BC affiliated 
with a HMO in Colombia and distributed in 16 cities of the country, in the period 
2010 to 2014. Demographic characteristics of the cohort are described and the aver-
